Try our Advanced Search for more refined results
Teva Pharmaceuticals USA, Inc. et al v. Sandoz, Inc. et al
Case Number:
1:08-cv-07611
Court:
Nature of Suit:
Judge:
Firms
- A&O Shearman
- ArentFox Schiff
- Friedman Kaplan
- Giaccio LLC
- Gibson Dunn
- Goodwin Procter
- Morrison Foerster
- Perkins Coie
- Weil Gotshal
Companies
- Momenta Pharmaceuticals Inc.
- Novartis AG
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
February 11, 2015
Teva Loses Bid For Sales Ban On Generic Copaxone
A New York federal judge on Tuesday rejected Teva Pharmaceuticals USA Inc.'s bid to block sales of generic versions of its multiple sclerosis drug Copaxone following a recent U.S. Supreme Court patent decision, ruling that he had no authority to grant Teva's request.
-
February 02, 2015
Teva Asks Judge To Bar Generic Copaxone During Remand
Teva Pharmaceuticals USA Inc. asked a federal judge Friday to block sales of generic versions of its multiple sclerosis drug Copaxone during the remand of a recent U.S. Supreme Court ruling that vacated a decision invalidating a key patent covering the drug.
-
June 25, 2012
Mylan, Sandoz Infringed Teva's MS Drug Patents, Judge Finds
In a major win for Teva Pharmaceutical Industries Ltd., a judge has ruled that Mylan Pharmaceuticals Inc. and Sandoz Inc. infringed the Israeli drugmaker's patents for Copaxone in making generic versions of the multiple sclerosis drug.